NCT00768976

Brief Summary

The primary objective of this study is to evaluate the quality of the clinical trial experience of cancer patients participating in cancer research studies through Summa Health System Hospitals Cancer Research Program by evaluating patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment. The secondary objective of this study is to determine areas for improvement to make the patient's clinical trial experience a satisfying and positive journey.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2008

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2008

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

October 7, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 8, 2008

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
Last Updated

May 23, 2012

Status Verified

May 1, 2012

Enrollment Period

3.6 years

First QC Date

October 7, 2008

Last Update Submit

May 22, 2012

Conditions

Cancer

Keywords

Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.

Outcome Measures

Primary Outcomes (1)

  • Evaluation of surveys to determine if there are opportunities for performance and/or quality improvement projects.patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment.

    Survey will be sent to subject 3 months after study registration

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.

You may qualify if:

  • Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.
  • Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.

You may not qualify if:

  • Participant has withdrawn consent for clinical trial participation and/or follow up.
  • Participant has a major medical illness that would prevent completion of the survey.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Joyce Neading, RHIT, CTR

    Summa Health System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Program Director, Cancer Research & Cancer Registry

Study Record Dates

First Submitted

October 7, 2008

First Posted

October 8, 2008

Study Start

October 1, 2008

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

May 23, 2012

Record last verified: 2012-05